STOCK TITAN

Haleon (NYSE: HLN) director adds 498 shares through dividend reinvestment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc reported a small share transaction by a senior board member under UK Market Abuse Regulation disclosure rules. Senior Independent Non-Executive Director Alan Stewart acquired 498 ordinary shares of Haleon through a dividend reinvestment on 14 May 2026 at a price of £3.3105 per share on the London Stock Exchange. This is a routine reinvestment of dividends into additional Haleon shares rather than an open-market purchase.

Positive

  • None.

Negative

  • None.
Shares acquired 498 shares Ordinary shares acquired via dividend reinvestment
Acquisition price £3.3105 per share Price for Haleon ordinary shares on 14 May 2026
Transaction date 14 May 2026 Date of dividend reinvestment share acquisition
Insider role Senior Independent Non-Executive Director Position held by Alan Stewart at Haleon
Person Discharging Managerial Responsibilities financial
"notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by a Person Discharging Managerial Responsibilities"
A person discharging managerial responsibilities is an individual who holds a senior role with authority to make or influence a company’s strategic or operational decisions, such as executives, board members, or other top managers. Investors care because these people often have access to confidential information and their buying or selling of company shares must be disclosed—like a referee who knows the score before the crowd, their actions can signal important, non-public insights about a company's prospects.
dividend reinvestment financial
"Nature of the transaction | Acquisition of Ordinary Shares as a result of dividend reinvestment"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
UK Market Abuse Regulation regulatory
"notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation"
Senior Independent Non-Executive Director financial
"Position/status | Senior Independent Non-Executive Director"
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
18 May 2026 - Director/PDMR Shareholding
 
 
 
 
99.1
 
 
 Haleon plcDirector/PDMR Shareholding 
 
18 May 2026: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by a Person Discharging Managerial Responsibilities ("PDMR").
 
On 15 May 2026, the Company received notification of the following transaction as detailed below.
 
1  
 
Details of the issuer, emission allowance market participant
 
a)  
 
Name  
 
Haleon plc
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
Senior Independent Non-Executive Director
b)  
 
Initial notification /Amendment  
 
Initial Notification 
3  
 
Details of the person discharging managerial responsibilities / person closely associated ("PCA") 
a)  
 
PDMR/PCA 
PDMR 
b)  
 
Name
 
Alan Stewart
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of Instrument  
 
Identification code  
 
Share
 
GB00BMX86B70   
 
b)  
 
Nature of the transaction  
 
Acquisition of Ordinary Shares as a result of dividend reinvestment
 
c)  
 
Currency, Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
 
Volume(s) 
 
 
 
£3.3105
 
498
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
N/A
 
 
- Price 
 
 
 
e)  
 
Date of the transaction  
 
14 May 2026
 
f)  
 
Place of the transaction  
 
London Stock Exchange (XLON) 
 
Amanda Mellor
Company Secretary
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as AdvilCentrumOtrivinPanadolparodontaxPolidentSensodyneTheraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: May 18, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary



FAQ

What insider share transaction did Haleon (HLN) disclose in this 6-K?

Haleon disclosed that Senior Independent Non-Executive Director Alan Stewart acquired 498 ordinary shares. The shares were obtained on 14 May 2026 through a dividend reinvestment at £3.3105 per share on the London Stock Exchange.

Who is the Haleon (HLN) insider involved in the May 2026 share transaction?

The insider is Alan Stewart, Haleon’s Senior Independent Non-Executive Director. He acquired 498 ordinary shares via dividend reinvestment, a routine mechanism where cash dividends are automatically used to buy more company shares.

At what price were the new Haleon (HLN) shares acquired by the director?

The shares were acquired at £3.3105 per ordinary share. This price applied to the 498 Haleon shares purchased through dividend reinvestment on 14 May 2026 on the London Stock Exchange.

What was the transaction date for the Haleon (HLN) director’s share acquisition?

The transaction took place on 14 May 2026. On that date, 498 Haleon ordinary shares were acquired for Alan Stewart through a dividend reinvestment arrangement on the London Stock Exchange.

How were the Haleon (HLN) shares acquired in this director/PDMR disclosure?

The shares were acquired through dividend reinvestment, not a standard open-market purchase. Cash dividends owed were used automatically to buy 498 additional Haleon ordinary shares at £3.3105 each.

Why did Haleon (HLN) publish this director shareholding update?

Haleon published the update to comply with UK Market Abuse Regulation. Transactions by Persons Discharging Managerial Responsibilities, such as Alan Stewart, must be publicly disclosed to provide transparency about insider dealings.